The One and Only
BOTOX® Cosmetic
BOTOX® Cosmetic is FDA approved for the temporary improvement in the appearance of moderate to severe forehead lines, lateral canthal lines, and glabellar lines in adults.1
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– Moderate to severe lateral canthal lines associated with orbicularis oculi activity
– Moderate to severe forehead lines associated with frontalis activity
DR.CYJ HAIR FILLER
The treatment with Dr. CYJ hair filler is offered by SelanCare in the Netherlands and Belgium. The hair filler is an injectable based on a peptide-hyaluronic acid formula. Dr. CYJ Hair Filler is injected into dermis layer at the site of the damaged scalp in need of implantation for the treatment of subcutaneous tissue damage caused by chemical, physical and traumatic effects of wounded scalp. The product is the result of thirteen years of research by Caregen and was first launched in 2016. Dr. CYJ hair filler is a medical device class III with a CE mark (CE 2265).
WHAT IS JUVÉDERM®?
JUVÉDERM® is a collection of 6 unique hyaluronic acid (HA) dermal fillers that temporarily add volume for different needs in seven specific areas of the face.
HOW DOES JUVÉDERM® WORK?
During treatment, a JUVÉDERM® filler is injected into the treatment area by a licensed specialist using a needle or cannula. JUVÉDERM® fillers add volume to the treatment area. Results with JUVÉDERM® fillers are not permanent, and retreatment is usually needed to maintain your results.
WHAT IS HYALURONIC ACID?
Hyaluronic Acid (HA) is a sugar naturally produced by the body that retains moisture in the skin. The main ingredient in JUVÉDERM® fillers is a modified form of HA. JUVÉDERM® fillers temporarily restore volume loss in certain areas of the face and help provide long-lasting, natural-looking results.
WHAT IS VYCROSS® TECHNOLOGY?
Vycross® Technology is a proprietary technology designed by Allergan Aesthetics for use in the JUVÉDERM® Collection of Fillers, specifically JUVÉDERM® VOLUMA® XC, JUVÉDERM® VOLBELLA®XC, and JUVÉDERM® VOLLURE® XC.
The unique Vycross® Technology process cross-links the hyaluronic acid (HA) molecules in these JUVÉDERM® fillers (pictured right), that results in a specialized, smooth gel filler. The safety and effectiveness of Vycross® Technology has been widely studied. Ask your licensed specialist about Vycross® Technology to learn more.
Where is JUVÉDERM® used?
Different formulations are approved to either volumize cheeks, smooth smile lines, smooth lines around the mouth, plump the lips, define the chin, improve the jawline, or improve the appearance of undereye hollows. The results are long-lasting, and can be customized by your licensed specialist to help you achieve your aesthetic goals.
The JUVÉDERM® Collection of Fillers are for adults over 21.
JUVÉDERM® VOLLURE® XC softens moderate to severe facial wrinkles and folds (eg, nasolabial folds) by adding volume around the nose and mouth.
JUVÉDERM® VOLUMA® XC is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile.
JUVÉDERM® VOLBELLA® XC adds volume to the lips for a subtle plump, softens the appearance of perioral lines, and improves the appearance of undereye hollows.
JUVÉDERM® ULTRA PLUS XC smooths moderate to severe facial wrinkles and folds around your nose and mouth.
JUVÉDERM® ULTRA XC adds fullness and plumps lips as well as smooths and corrects moderate to severe wrinkles and folds in adults.
JUVÉDERM® VOLUX® XC adds volume along the jawline area to improve jawline definition in patients with moderate to severe loss. The added volume augments the shape and structure of the lower face.
JUVÉDERM® Injectable Gel Fillers Important Safety Information
ARE THERE ANY REASONS WHY I SHOULD NOT RECEIVE ANY JUVÉDERM® FORMULATION?
Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), if you are allergic to lidocaine or the Gram-positive bacterial proteins used in these products, or if you have had previous allergic reactions to hyaluronic acid fillers.
WHAT WARNINGS SHOULD MY DOCTOR ADVISE ME ABOUT?
- One of the risks with using dermal fillers is the unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. Most of these events are irreversible.
- If you have changes in your vision, signs of a stroke (including sudden difficulty speaking, numbness or weakness in your face, arms or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.
- The use of dermal fillers where skin sores, pimples, rashes, hives, cysts, or infections are present should be postponed, as this may delay healing or make skin problems worse.
- The effectiveness of removal of any dermal filler has not been studied.
WHAT PRECAUTIONS SHOULD MY DOCTOR ADVISE ME ABOUT?
- JUVÉDERM® VOLBELLA® XC should only be injected into undereye hollows by doctors who have completed the necessary training for this treatment area. To find a doctor, visit Juvederm.com/find-a-specialist. Doctors who complete the training will be listed with a symbol
- The safety of these products for use during pregnancy or while breastfeeding has not been studied
- The safety of JUVÉDERM® VOLUMA® XC has not been studied in patients under 35 years or over 65 years for cheek augmentation, or under 22 years and over 80 years for chin augmentation. The safety of JUVÉDERM® VOLUX® XC, JUVÉDERM® VOLLURE® XC and JUVÉDERM® VOLBELLA® XC has not been studied in patients under 22 years, and the safety of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC has not been studied in patients under 18 years
- The safety of JUVÉDERM® VOLUMA® XC has not been studied in patients under 35 years or over 65 years for cheek augmentation, or under 22 years and over 80 years for chin augmentation. The safety of JUVÉDERM® VOLUX® XC, JUVÉDERM® VOLLURE® XC and JUVÉDERM® VOLBELLA® XC has not been studied in patients under 22 years, and the safety of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC has not been studied in patients under 18 years
- The safety and effectiveness of treatment with JUVÉDERM® products in anatomical regions outside of their approved uses have not been established in clinical studies
- If you have a history of excessive scarring (thick, hard scars) or pigmentation disorders, treatment in these patients has not been studied and may result in additional scars or changes in pigmentation
- If you are planning other procedures including laser treatments or a chemical peel, there is a possible risk of inflammation at the treatment site if these procedures are performed closely before or after JUVÉDERM® injectable gel treatment
- Tell your doctor if you are on therapy used to reduce your body’s natural defense system (such as steroids, chemotherapy, and medicines to treat autoimmune diseases, HIV, and AIDs), as these may increase your risk of infection; and medications that can prolong bleeding (such as aspirin, ibuprofen, or other blood thinners), as these may result in increased bruising or bleeding at the injection site.
- Avoid applying makeup for 12 hours after treatment and minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment, as these may cause temporary redness, swelling, and/or itching at the injection site
- JUVÉDERM® VOLUMA® XC was not studied in patients with significant loose skin of the chin, neck, or jaw
- The effect of JUVÉDERM® VOLUMA® XC injection into the chin on facial hair growth has not been studied
- Patients who experience skin injury near the site of JUVÉDERM® VOLUMA® XC injection may be at a higher risk for adverse events
- Tell your doctor if you have already been injected with dermal fillers in the same area as the one(s) you are about to be treated for. This information helps your doctor decide when and whether you should get treatment
WHAT ARE POSSIBLE SIDE EFFECTS OF TREATMENT?
The most commonly reported side effects with JUVÉDERM® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also reported.
These side effects are consistent with other facial injection procedures and most will resolve within 30 days. Your doctor may choose to treat side effects persisting longer with antibiotics, steroids, or hyaluronidase (an enzyme that breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
Mesoestetic C.Prof 210 Depigmentation
Mesoestetic c.prof 210 depigmentation solution is a powerful combination of active ingredients with corrective action of pigment disorders and anti-oxidant. It acts regulating melanin production and removing the melanin present in epidermal cells, responsible for visible pigmentation. It also contains antioxidant agents that regulate melanin overproduction.
Treatment of moderate hyperpigmentation (solar or senile lentigo) or PIH (post-inflammatory hyperpigmentation) in fair and medium phototypes (I-III). Evens out skin tone. Provides brightness and vitality
What are RADIESSE® and RADIESSE® (+)?
RADIESSE® and RADIESSE® (+) are dermal fillers that are used for smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases that extend from the corner of your nose to the corner of your mouth). RADIESSE® is also used for correcting volume loss in the back of the hands.
RADIESSE® and RADIESSE® (+) IMPORTANT CONSUMER SAFETY INFORMATION
Who should not use RADIESSE® or RADIESSE® (+)?
You should not use RADIESSE® or RADIESSE® (+) if you have an allergy to any component of the product, if you have a history of severe allergies, if you have a bleeding disorder, or if you are pregnant or breastfeeding. You should not use RADIESSE® (+) if you have an allergy to lidocaine or medicines like it.
What is the most important information I should know about RADIESSE® and RADIESSE® (+)?
One of the risks with using these products is unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious, and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. If you have changes in your vision, signs of a stroke (including sudden difficulty speaking, numbness or weakness in your face, arms, or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.
As with all procedures that involve an injection through the skin, there is a risk of infection.
Do not use RADIESSE® or RADIESSE® (+) if you have a skin infection until it has healed.
It is not known if RADIESSE® or RADIESSE® (+) is safe or effective in the lips, or in the area around the eyes.
The microspheres in RADIESSE® and RADIESSE® (+) can be seen in X-rays and CT Scans. It is very important that you tell your health care provider that you have had RADIESSE® or RADIESSE® (+) dermal filler.
If you have a history of herpes, you may experience a herpes breakout after receiving RADIESSE® or RADIESSE® (+).
Injection in the back of the hand may result in temporary difficulty performing activities. RADIESSE® may cause nodules, bumps or lumps in the back of the hand and can last up to 1 year.
You should minimize strenuous activity and avoid extensive sun or heat exposure for about 24 hours after treatment and until any swelling or redness has resolved.
What should I tell my doctor before using RADIESSE® or RADIESSE® (+)?
Tell your health care provider if you are taking blood thinners or medicines that can interfere with the clotting of blood, such as aspirin or warfarin. These medicines might make it more likely that you will experience bruising or bleeding at the injection site. Tell your health care provider if you have any diseases, injuries or disabilities of the hand, if you have a history forming large, raised scars or if you have had any other skin treatments such as skin peels.
What are the most common adverse events with RADIESSE® or RADIESSE® (+)?
The most common adverse events seen in clinical studies of RADIESSE® used in the hands include bruising, redness, swelling, pain, itching, nodules or bumps/lumps, difficulty performing activities, loss of sensation and other local side effects. The most common adverse events seen in clinical studies of RADIESSE® or RADIESSE® (+) used in the face include bruising, redness, swelling, pain, itching and other local side effects
These are not all of the possible side effects with RADIESSE® or RADIESSE® (+). Merz collects information about adverse events seen with RADIESSE® and RADIESSE® (+) outside of clinical studies. These events are included in the RADIESSE® and RADIESSE® (+) Patient Information Guide based on an assessment of seriousness and potential causal relationship to RADIESSE® or RADIESSE® (+). Please see the Patient Information Guide available at www.radiesse.com for list of these events. Tell your health care provider about any side effects that bother you or do not go away.
Restylane
Dermal fillers are injection treatments used to diminish wrinkles, restore fullness, or make subtle changes. Hyaluronic acid (HA) is a naturally occurring substance in your skin that helps provide hydration, fullness, and elasticity.1 It diminishes as we age, causing skin to lose volume while increasing the chances for wrinkles and folds to appear.
Restylane dermal fillers use clear gel formulations of HA. As the original non-animal stabilized HA filler, Restylane was designed to be closest to the body’s own hyaluronic acid with minimal crosslinking,2*† and was the first to be approved by the US FDA. The Restylane portfolio has now been used in over 65 million treatments worldwide.3
*Depending on the product used and area treated.
†NASHA products (Restylane-L, Restylane Lyft, Restylane Silk, and Restylane Eyelight) have less than 1% crosslinking.
Restylane® and Restylane-L® are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane® and Restylane-L® are also indicated for injection into the lips.
Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies. Restylane® Lyft with Lidocaine is also indicated for injection into the dorsal hand to correct volume loss.
Restylane® Silk is for lip augmentation and for correction of perioral wrinkles.
Restylane® Kysse is for lip augmentation and for correction of upper perioral wrinkles.
Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds. Restylane® Defyne is also indicated for injection into the mid-to-deep dermis (subcutaneous and/or supraperiosteal) for augmentation of the chin region to improve the chin profile in patients with mild to moderate chin retrusion.
Restylane® Contour is for cheek augmentation and for the correction of midface contour deficiencies.
Restylane® Eyelight is for the improvement of infraorbital hollowing.
Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, prone to bleeding, or have a bleeding disorder. The safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders as these side effects can occur with hyaluronic acid fillers. Tell your doctor if you are planning other cosmetic treatments (i.e., lasers and chemical peels) as there is a possible risk of inflammation at the injection site.
Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Using these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete.
The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent including, vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.
Revitalash®
Revitalash® began in 2006 with one product created by a physician to help his beloved wife feel beautiful during her courageous fight against breast cancer. Today, RevitaLash® Cosmetics offers an entire collection designed to enhance the health and natural beauty of your lashes, brows, and hair—while giving back to the cause that started it all every day of the year.
RHA® Collection of Fillers
DYNAMIC STRENGTH SCORE (Pa2)
The gel’s ability to retain its G’ and physical characteristics over a wide range of applied forces.
STRETCH SCORE (%/S)
The gel’s ability to extend without disruption when subjected to continuous pressure.
Indications: The RHA® Collection of resilient hyaluronic acid (HA) fillers includes RHA Redensity™, RHA® 2, RHA® 3 and RHA® 4. RHA Redensity™ is indicated for injection into the dermis and superficial dermis of the face, for the correction of moderate to severe dynamic perioral rhytids in adults 22 or older. RHA® 2 is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds in adults 22 or older. RHA® 3 is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds and is also indicated for injection into the vermillion body, vermillion border and oral commissure to achieve lip augmentation and lip fullness in adults 22 or older. RHA® 4 is indicated for injection in the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds in adults 22 or older.
IMPORTANT SAFETY INFORMATION
Contraindications: Do not use in patients who have severe allergies, marked by a history of anaphylaxis or multiple severe allergies, or in patients with a history of allergies to gram-positive bacterial proteins or local anesthetics of the amide type, such as lidocaine. Do not use in patients with bleeding disorders.
Warnings: Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur. Product use at specific sites in which an active inflammatory process or infection is present should be deferred until the underlying process has been controlled.
Precautions: These products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy.
Discuss the potential risks of soft-tissue injections with your patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications.
The safety and effectiveness for the treatment of anatomic regions other than the labeled indications have not been established in controlled U.S. clinical studies.
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Standard precautions associated with injectable materials should be followed.
The safety for use in sites in the presence of other implants, during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied.
Use with caution in patients on immunosuppressive therapy.
Patients who are using products that can prolong bleeding (such as thrombolytics, anticoagulants, or inhibitors of platelet aggregation) may experience increased bruising or bleeding at treatment sites.
Patients with a history of herpetic eruptions may experience reactivation of the herpes.
There is a possible risk of inflammation at the implant site if laser treatments or a chemical peel are performed after treatment.
Use as supplied. Modification or use of the product outside the Directions for Use may adversely impact the sterility, safety, homogeneity, or performance of the product. For single patient use. Do not reuse a syringe between two treatments and/or between two patients. Do not resterilize.
Adverse Events: The most commonly reported side effects were firmness, redness, tenderness, swelling, lumps/bumps, bruising, discoloration, pain and itching. Most of these events were mild or moderate and resolved within 14 days. Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers. Cases of delayed-onset inflammation have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own.
Sculptra
What is collagen?
Collagen is a fibrous protein that helps maintain your skin’s shape and structure. The skin needs collagen to resist signs of aging, such as fine lines, wrinkles, and sagging.3-5 By age 40, most of us have lost up to 20% of our natural collagen.2
Sculptra helps stimulate natural collagen production.6 The poly-L-lactic acid (PLLA-SCA) in Sculptra forms a framework that helps support and maintain the skin’s inner structure, which may lead to a more youthful-looking appearance.1,3-5
Sculptra works deep within the sPL-SCA works underneath the skin to help restore the skin’s inner structure.6,7
As Sculptra PLLA-SCA microparticles are absorbed, they help stimulate and restore your own natural collagen production.1,6
Gradually restoring skin quality8,9
Boost natural collagen, improve skin quality, and bring out your youthful glow with Sculptra1-4*
Not just another filler. Sculptra is a biostimulatory aesthetic injectable that helps stimulate your own natural collagen production to smooth facial wrinkles and improve skin tightness, revealing a refreshed-looking you.1,2,5
Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.
Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age.
Sculptra has unique injection requirements and should only be used by a trained healthcare practitioner. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment.
Sculptra should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete. Sculptra should not be injected into the red area (vermillion) of the lip or in the peri-orbital area.
The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported.
SkinCeuticals®
SkinCeuticals® is dedicated to improving skin health using science-backed products. Born from decades of skin cancer research that led to pivotal breakthroughs in antioxidants, their high-potency formulas are concentrated in pure actives and proven to penetrate optimally into the skin. SkinCeuticals® is made in the USA, and their clinical skincare is used by dermatologists, plastic surgeons, and medi-spas for daily homecare and to complement aesthetic procedures. They formulate their products to correct signs of aging, protect healthy skin, and prevent future damage.
